Search research articles
Contact Us
Filters
Showing results (11-20 of 101) with videos related to
Page
of 11
Sort By:
Translational Oncology
|
May 18, 2026
The Sig27 multigene stratifies breast cancer fatality risk via reflecting tumor-associated immune suppressive features
Yingying Su, Ying Dong, Tao Zhang, et al.
Cancer Letters
|
February 11, 2014
PKM2 contributes to cancer metabolism
Nicholas Wong, Diane Ojo, Judy Yan, et al.
Cellular Signalling
|
July 20, 2010
Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation
Fengxiang Wei, Yanyun Xie, Lijian Tao, et al.
Plos One
|
April 27, 2013
Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation
Adrian P Rybak, Alistair J Ingram, Damu Tang
Oncotarget
|
November 23, 2017
BMI1 reduces ATR activation and signalling caused by hydroxyurea
Xiaozeng Lin, Fengxiang Wei, Peter Whyte, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
December 18, 2017
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer
Diane Ojo, Ying Wu, Anita Bane, et al.
The Journal of Clinical Investigation
|
May 12, 2010
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells
Lizhi He, Alistair Ingram, Adrian P Rybak, et al.
Endocrine-Related Cancer
|
November 4, 2025
Sig27 stratifies prostate cancer recurrence by assessing the immunosuppressive properties of tumors
Sandra Vega Neira, Ying Dong, Tao Zhang, et al.
Cancer Investigation
|
June 27, 2009
Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma
Hui Xu, Lizhi He, Xinchang Feng, et al.
Cellular Signalling
|
September 16, 2010
ERK1 and ERK2 kinases activate hydroxyurea-induced S-phase checkpoint in MCF7 cells by mediating ATR activation
Fengxiang Wei, Yanyun Xie, Lizhi He, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 101) with videos related to
Sort By:
Page
of 11
Translational Oncology
|
May 18, 2026
The Sig27 multigene stratifies breast cancer fatality risk via reflecting tumor-associated immune suppressive features
Yingying Su, Ying Dong, Tao Zhang, et al.
Cancer Letters
|
February 11, 2014
PKM2 contributes to cancer metabolism
Nicholas Wong, Diane Ojo, Judy Yan, et al.
Cellular Signalling
|
July 20, 2010
Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation
Fengxiang Wei, Yanyun Xie, Lijian Tao, et al.
Plos One
|
April 27, 2013
Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation
Adrian P Rybak, Alistair J Ingram, Damu Tang
Oncotarget
|
November 23, 2017
BMI1 reduces ATR activation and signalling caused by hydroxyurea
Xiaozeng Lin, Fengxiang Wei, Peter Whyte, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
December 18, 2017
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer
Diane Ojo, Ying Wu, Anita Bane, et al.
The Journal of Clinical Investigation
|
May 12, 2010
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells
Lizhi He, Alistair Ingram, Adrian P Rybak, et al.
Endocrine-Related Cancer
|
November 4, 2025
Sig27 stratifies prostate cancer recurrence by assessing the immunosuppressive properties of tumors
Sandra Vega Neira, Ying Dong, Tao Zhang, et al.
Cancer Investigation
|
June 27, 2009
Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma
Hui Xu, Lizhi He, Xinchang Feng, et al.
Cellular Signalling
|
September 16, 2010
ERK1 and ERK2 kinases activate hydroxyurea-induced S-phase checkpoint in MCF7 cells by mediating ATR activation
Fengxiang Wei, Yanyun Xie, Lizhi He, et al.
Page
of 11